Artemisinin-resistant malaria in the Asia-Pacific region

@article{Tulloch2013ArtemisininresistantMI,
  title={Artemisinin-resistant malaria in the Asia-Pacific region},
  author={J. L. Tulloch and Benedict David and Robert David Newman and Sylvia R. Meek},
  journal={The Lancet},
  year={2013},
  volume={381},
  pages={e16-e17}
}

Lessons for improved COVID-19 surveillance from the scale-up of malaria testing strategies

By learning from the successful elements of malaria control programmes, it is clear that improving access to point-of-care testing strategies for CO VID-19 will provide a suitable framework for COVID-19 diagnosis in not only the Asia Pacific, but all malarious countries.

Microbial proteasomes as drug targets

The strategies and pharmacophores that have been used in developing proteasome inhibitors with potency and selectivity that spare human proteasomes are described and the development of clinical proteAsome inhibitor candidates for treatment of leishmaniasis and Chagas disease are highlighted.

A PCR-Based Technique to Track the Geographic Origin of Plasmodium falciparum With 23-SNP Barcode Analysis

This study aims to explore the feasibility of using the 23-SNP barcode for tracking P. falciparum by polymerase chain reaction and sequencing, while providing geographical haplotypes of isolates that originated from Central Africa.

Mapping the travel patterns of people with malaria in Bangladesh

The approach demonstrated here provides a framework for identifying key traveller groups and their origins and destinations of travel in combination with knowledge of local epidemiology to inform malaria control and elimination efforts.

Using An Ecosystem Approach To Understand The Link Between Artisanal Capture Fishing And Malaria On Mageta Island In Western Kenya

......................................................................................................................... XII CHAPTER ONE: INTRODUCTION

Ready for malaria elimination: zero indigenous case reported in the People’s Republic of China

Malaria elimination in China is a country-led and country-owned endeavour supported by two systems, namely a case-based surveillance and response system and reference laboratory system, which can probably help improving malaria surveillance systems in China, but also in other elimination countries.

Unpacking 'Artemisinin Resistance'.

Antimalarials inhibit hematin crystallization by unique drug–surface site interactions

It is shown that quinoline-class drugs work by specific interactions with β-hematin crystals, which are the by-product of heme detoxification within the digestive vacuole of the parasites, and the significance of drug–crystal interactions is revealed.

References

SHOWING 1-6 OF 6 REFERENCES

Impact of chloroquine resistance on malaria mortality.

A new clothing impregnation method for personal protection against ticks and biting insects.

The threat of artemisinin-resistant malaria.

Reduced susceptibility of Plasmodium falciparum to artemisinin is now being seen in some places, indicating reduced susceptibility to malaria control.

World malaria report 2011

The World Health Organization (WHO) World Malaria Report 2021 estimates that there were 241 million malaria cases, including 627,000 deaths, worldwide in 2020, which represents around 14 million more cases, and 69,000 more deaths, than 2019.

Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border

Emerging resistance in Southeast Asia raises concern over possible spread or similar evolution of resistance to other artemisinin-based combination therapies in Africa.